Segment disclosures

Company overview

Editas Medicine, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=edit:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3011890000 USD20260805Open filing evidence
2026-01-01 – 2026-06-3014721000 USD20260805Open filing evidence
2026-01-01 – 2026-03-312831000 USD20260505Open filing evidence
2025-01-01 – 2025-12-3140520000 USD20260309Open filing evidence
2025-07-01 – 2025-09-307543000 USD20251110Open filing evidence
2025-01-01 – 2025-09-3015779000 USD20251110Open filing evidence
2025-04-01 – 2025-06-303578000 USD20260805Open filing evidence
2025-01-01 – 2025-06-308236000 USD20260805Open filing evidence
2025-01-01 – 2025-03-314658000 USD20260505Open filing evidence
2024-01-01 – 2024-12-3132314000 USD20260309Open filing evidence
2024-07-01 – 2024-09-3061000 USD20251110Open filing evidence
2024-01-01 – 2024-09-301710000 USD20251110Open filing evidence
2024-04-01 – 2024-06-30513000 USD20250812Open filing evidence
2024-01-01 – 2024-06-301649000 USD20250812Open filing evidence
2024-01-01 – 2024-03-311135000 USD20250512Open filing evidence
2023-01-01 – 2023-12-3178123000 USD20250305Open filing evidence
2022-01-01 – 2022-12-3119712000 USD20250305Open filing evidence